EDGAR Filing Documents for 0001193125-17-263664

Form 8-K - Current report:

SEC Accession No. 0001193125-17-263664

Filing Date

2017-08-21

Accepted

2017-08-21 16:09:04

Documents

Period of Report

2017-08-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d436888d8k.htm	8-K	28703
2	EX-3.1	d436888dex31.htm	EX-3.1	254142
3	EX-5.1	d436888dex51.htm	EX-5.1	9241
4	EX-99.1	d436888dex991.htm	EX-99.1	8095
5	GRAPHIC	g436888g06c17.gif	GRAPHIC	2509
6	GRAPHIC	g436888g20x98.gif	GRAPHIC	3491
7	GRAPHIC	g436888g54o73.gif	GRAPHIC	1988
8	GRAPHIC	g436888g87l64.gif	GRAPHIC	3187
	Complete submission text file	0001193125-17-263664.txt		317031

Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878

Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450

Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)